Show All
-
Our corporate headquarters are located at 23515 NE Novelty Hill Road, Suite B221 #125 Redmond, WA 98053.
-
The Company was founded in 2018.
-
The Company is incorporated in Delaware.
-
Eliem Therapeutics completed its IPO on August 10, 2021 at a price of $12.50.
-
The Company’s fiscal year ends December 31st.
-
Our common stock is listed on the NASDAQ Market under the symbol “ELYM”.
-
The transfer agent and registrar for the common stock of Eliem Therapeutics’ stock is
American Stock Transfer & Trust Company, LLC
6201 15th Ave,
Brooklyn, NY 11219
(800) 937-5449 -
For questions about your stock please contact our transfer agent, American Stock Transfer & Trust Company, LLC
-
To change the address on your shareholder account you must send both your old and new addresses to our transfer agent, American Stock Transfer & Trust Company, LLC 6201 15th Ave, Brooklyn, NY 11219
To transfer stock or replace a lost stock certificate, contact our transfer agent, American Stock Transfer & Trust Company, LLC
-
The auditor for Eliem Therapeutics is PricewaterhouseCoopers located in Seattle, WA.
-
Legal counsel for Eliem Therapeutics is Cooley LLP located in Seattle, WA.
-
To find out more about Eliem Therapeutics visit our webpage at www.eliemtx.com.
-
Eliem Therapeutics press release archive can be viewed under the “Press Releases” section of the “Investors” page and financial reports are available under the “Financials & Filings” section located at our website: www.eliemtx.com.
-
Eliem Therapeutics SEC Filings can be found on www.sec.gov and are also available under the “Financials & Filings” section of the “Investors” page located at our website www.eliemtx.com.
-
For a list of the Executive Management team and Board of Directors please visit the “Team” tab of our website.
-
For investor inquiries please contact:
Eliem Therapeutics
EMAIL: InvestorRelations@eliemtx.comChristopher F. Brinzey
Westwicke Partners for Eliem Therapeutics
EMAIL: chris.brinzey@westwicke.com
PHONE: + 1 339-970-2843